The latest closing stock price for Sage Therapeutics as of March 28, 2025 is 8.28.
An investor who bought $1,000 worth of Sage Therapeutics stock at the IPO in 2014 would have $-725 today, roughly -1 times their original investment - a -11.07% compound annual growth rate over 11 years.
The all-time high Sage Therapeutics stock closing price was 192.33 on February 01, 2018.
The Sage Therapeutics 52-week high stock price is 17.79, which is 114.9% above the current share price.
The Sage Therapeutics 52-week low stock price is 4.62, which is 44.2% below the current share price.
The average Sage Therapeutics stock price for the last 52 weeks is 8.83.
An investor who bought $1,000 worth of Sage Therapeutics stock at the IPO in 2014 would have $-725 today, roughly -1 times their original investment - a -11.07% compound annual growth rate over 11 years.
The all-time high Sage Therapeutics stock closing price was 192.33 on February 01, 2018.
The Sage Therapeutics 52-week high stock price is 17.79, which is 114.9% above the current share price.
The Sage Therapeutics 52-week low stock price is 4.62, which is 44.2% below the current share price.
The average Sage Therapeutics stock price for the last 52 weeks is 8.83.